Literature DB >> 10972245

Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat.

K I Strauss1, M F Barbe, R M Marshall, R Raghupathi, S Mehta, R K Narayan.   

Abstract

Cyclooxygenase-2 (COX2) is a primary inflammatory mediator that converts arachidonic acid into precursors of vasoactive prostaglandins, producing reactive oxygen species in the process. Under normal conditions COX2 is not detectable, except at low abundance in the brain. This study demonstrates a distinctive pattern of COX2 increases in the brain over time following traumatic brain injury (TBI). Quantitative lysate ribonuclease protection assays indicate acute and sustained increases in COX2 mRNA in two rat models of TBI. In the lateral fluid percussion model, COX2 mRNA is significantly elevated (>twofold, p < 0.05, Dunnett) at 1 day postinjury in the injured cortex and bilaterally in the hippocampus, compared to sham-injured controls. In the lateral cortical impact model (LCI), COX2 mRNA peaks around 6 h postinjury in the ipsilateral cerebral cortex (fivefold induction, p < 0.05, Dunnett) and in the ipsilateral and contralateral hippocampus (two- and six-fold induction, respectively, p < 0.05, Dunnett). Increases are sustained out to 3 days postinjury in the injured cortex in both models. Further analyses use the LCI model to evaluate COX2 induction. Immunoblot analyses confirm increased levels of COX2 protein in the cortex and hippocampus. Profound increases in COX2 protein are observed in the cortex at 1-3 days, that return to sham levels by 7 days postinjury (p < 0.05, Dunnett). The cellular pattern of COX2 induction following TBI has been characterized using immunohistochemistry. COX2-immunoreactivity (-ir) rises acutely (cell numbers and intensity) and remains elevated for several days following TBI. Increases in COX2-ir colocalize with neurons (MAP2-ir) and glia (GFAP-ir). Increases in COX2-ir are observed in cerebral cortex and hippocampus, ipsilateral and contralateral to injury as early as 2 h postinjury. Neurons in the ipsilateral parietal, perirhinal and piriform cortex become intensely COX2-ir from 2 h to at least 3 days postinjury. In agreement with the mRNA and immunoblot results, COX2-ir appears greatest in the contralateral hippocampus. Hippocampal COX2-ir progresses from the pyramidal cell layer of the CA1 and CA2 region at 2 h, to the CA3 pyramidal cells and dentate polymorphic and granule cell layers by 24 h postinjury. These increases are distinct from those observed following inflammatory challenge, and correspond to brain areas previously identified with the neurological and cognitive deficits associated with TBI. While COX2 induction following TBI may result in selective beneficial responses, chronic COX2 production may contribute to free radical mediated cellular damage, vascular dysfunction, and alterations in cellular metabolism. These may cause secondary injuries to the brain that promote neuropathology and worsen behavioral outcome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972245      PMCID: PMC1456323          DOI: 10.1089/089771500415436

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  82 in total

1.  Differential cellular distribution and dynamics of HSP70, cyclooxygenase-2, and c-Fos in the rat brain after transient focal ischemia or kainic acid.

Authors:  O Sanz; A Estrada; I Ferrer; A M Planas
Journal:  Neuroscience       Date:  1997-09       Impact factor: 3.590

2.  Differential intracellular sorting of immediate early gene mRNAs depends on signals in the mRNA sequence.

Authors:  C S Wallace; G L Lyford; P F Worley; O Steward
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

3.  GABAergic presubicular projections to the medial entorhinal cortex of the rat.

Authors:  T van Haeften; F G Wouterlood; B Jorritsma-Byham; M P Witter
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

4.  Induction of cyclooxygenase-2 in the brain by cytokines.

Authors:  C Cao; K Matsumura; Y Watanabe
Journal:  Ann N Y Acad Sci       Date:  1997-03-15       Impact factor: 5.691

5.  Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release.

Authors:  C E Dixon; X Ma; D W Marion
Journal:  J Neurotrauma       Date:  1997-03       Impact factor: 5.269

6.  Prostaglandin H synthase-2 and cytosolic phospholipase A2 in the hypoxic-ischemic brain: role in neuronal death or survival?

Authors:  M Walton; E Sirimanne; C Williams; P D Gluckman; J Keelan; M D Mitchell; M Dragunow
Journal:  Brain Res Mol Brain Res       Date:  1997-10-15

7.  Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex.

Authors:  W J Lukiw; N G Bazan
Journal:  J Neurosci Res       Date:  1997-12-15       Impact factor: 4.164

8.  Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain.

Authors:  S Lacroix; S Rivest
Journal:  J Neurochem       Date:  1998-02       Impact factor: 5.372

9.  Induction of cyclooxygenase-2 following anoxic stress in piglet cerebral arteries.

Authors:  D W Busija; C Thore; T Beasley; F Bari
Journal:  Microcirculation       Date:  1996-12       Impact factor: 2.628

10.  Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage.

Authors:  S Nogawa; F Zhang; M E Ross; C Iadecola
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

View more
  42 in total

Review 1.  Therapies targeting lipid peroxidation in traumatic brain injury.

Authors:  Tamil Selvan Anthonymuthu; Elizabeth Megan Kenny; Hülya Bayır
Journal:  Brain Res       Date:  2016-02-10       Impact factor: 3.252

Review 2.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.

Authors:  Sang-Ho Choi; Saba Aid; Francesca Bosetti
Journal:  Trends Pharmacol Sci       Date:  2009-03-09       Impact factor: 14.819

4.  Strong Correlation of Genome-Wide Expression after Traumatic Brain Injury In Vitro and In Vivo Implicates a Role for SORLA.

Authors:  Michael R Lamprecht; Benjamin S Elkin; Kartik Kesavabhotla; John F Crary; Jennifer L Hammers; Jimmy W Huh; Ramesh Raghupathi; Barclay Morrison
Journal:  J Neurotrauma       Date:  2016-04-19       Impact factor: 5.269

5.  The associations of two SNPs in miRNA-146a and one SNP in ZBTB38-RASA2 with the disease susceptibility and the clinical features of the Chinese patients of sCJD and FFI.

Authors:  Chen Gao; Qiang Shi; Jing Wei; Wei Zhou; Kang Xiao; Jing Wang; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2018-01-02       Impact factor: 3.931

Review 6.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

7.  N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway.

Authors:  Daming Zhu; Xuan Wu; Kenneth I Strauss; Robert H Lipsky; Zehra Qureshi; Artin Terhakopian; Antonello Novelli; Krishna Banaudha; Ann M Marini
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

Review 8.  Chronic Histopathological and Behavioral Outcomes of Experimental Traumatic Brain Injury in Adult Male Animals.

Authors:  Nicole D Osier; Shaun W Carlson; Anthony DeSana; C Edward Dixon
Journal:  J Neurotrauma       Date:  2015-04-15       Impact factor: 5.269

9.  Variation in chronic nicotinamide treatment after traumatic brain injury can alter components of functional recovery independent of histological damage.

Authors:  Michael R Hoane; Jeremy L Pierce; Nicholas A Kaufman; Jason E Beare
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

10.  Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice.

Authors:  Matthew L Kelso; Stephen W Scheff; James R Pauly; Charles D Loftin
Journal:  BMC Neurosci       Date:  2009-08-31       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.